Rankings
▼
Calendar
FHTX FY 2019 Earnings — Foghorn Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
FHTX
Foghorn Therapeutics Inc.
$322M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$51M
Net Income
-$51M
EPS (Diluted)
$-1.40
Cash Flow
Operating Cash Flow
-$46M
Free Cash Flow
-$47M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$22M
Total Liabilities
$110M
Stockholders' Equity
-$88M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$2M
-$379,000
-373.1%
Operating Income
-$51M
-$26M
-96.1%
Net Income
-$51M
-$26M
-94.1%
← FY 2018
All Quarters
Q1 2019 →